Skip to Content
Merck
All Photos(3)

Key Documents

L7914

Sigma-Aldrich

Lipoprotein, low density from human plasma

≥95% (SDS-PAGE), solution

Synonym(s):

β-Lipoprotein, LDL, Low density lipoprotein

Sign Into View Organizational & Contract Pricing


About This Item

CAS Number:
MDL number:
UNSPSC Code:
12352211
NACRES:
NA.25

biological source

human plasma

Quality Level

Assay

≥95% (SDS-PAGE)

form

solution

UniProt accession no.

functional group

ester
phospholipid

shipped in

wet ice

storage temp.

2-8°C

Gene Information

Looking for similar products? Visit Product Comparison Guide

Application

Lipoprotein, low density from human plasma has been used:
  • as an additive in cholesterol-free RPMI media
  • as a component in buffer to perform an assay for measuring lipid peroxidation
  • to stimulate hepatic macrophages
  • as a plasma protein to determine pazopanib unbound fraction (fu%) by equilibrium dialysis

Biochem/physiol Actions

LDL and HDL transport both dietary and endogenous cholesterol in the plasma. LDL is the main transporter of cholesterol and cholesteryl esters and makes up more than half of the total lipoprotein in plasma. LDL is absorbed by the liver and other tissues via receptor mediated endocytosis. The cytoplasmic domain of the LDL receptor facilitates the formation of coated pits; receptor-rich regions of the membrane. The ligand binding domain of the receptor recognizes apo-B100 on LDL, resulting in the formation of a clathrin-coated vesicle. ATP-dependent proton pumps lower the pH inside the vesicle resulting dissociation of LDL from its receptor. After loss of the clathrin coat the vesicles fuse with lysozomes, resulting in peptide and cholesteryl ester enzymatic hydrolysis. The LDL receptor can be recycled to the cell membrane. Insulin, tri-iodothyronine and dexamethasome have shown to be involved with the regulation of LDL receptor mediated uptake.

Caution

Freezing of lipoprotein solutions may cause structural or compositional changes.

Physical properties

Low density lipoproteins are smaller than VLDL and IDL (26 nm) (MW approximately 3.5 million) and more dense (~1.04). The protein component of LDL is apolipoprotein B100. LDL contains 20-22% protein, 10-15% triglycerides, 20-28% phospholipids, 37-48% cholesteryl esters and 8-10% cholesterol.

Physical form

Solution in 150 mM NaCl and 0.01% EDTA, pH 7.4

Disclaimer

RESEARCH USE ONLY. This product is regulated in France when intended to be used for scientific purposes, including for import and export activities (Article L 1211-1 paragraph 2 of the Public Health Code). The purchaser (i.e. enduser) is required to obtain an import authorization from the France Ministry of Research referred in the Article L1245-5-1 II. of Public Health Code. By ordering this product, you are confirming that you have obtained the proper import authorization.

Storage Class Code

10 - Combustible liquids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Shu-Ping Hui et al.
Analytical and bioanalytical chemistry, 403(7), 1831-1840 (2012-03-01)
1-Palmitoyl-2-linoleoylphosphatidylcholine monohydroperoxide (PC 16:0/18:2-OOH) and 1-stearoyl-2-linoleoylphosphatidylcholine monohydroperoxide (PC 18:0/18:2-OOH) were measured by liquid chromatography/mass spectrometry (LC/MS) using nonendogenous 1-palmitoyl-2-heptadecenoylphosphatidylcholine monohydroperoxide as an internal standard. The calibration curves for synthetic PC 16:0/18:2-OOH and PC 18:0/18:2-OOH, which were obtained by direct injection
Leanne Satchell et al.
Biochemistry, 51(18), 3767-3775 (2012-04-13)
Low-density lipoprotein (LDL) has recently been shown to be oxidized by iron within the lysosomes of macrophages, and this is a novel potential mechanism for LDL oxidation in atherosclerosis. Our aim was to characterize the chemical and physical changes induced
Determination of unbound fraction of pazopanib in vitro and in cancer patients reveals albumin as the main binding site
Imbs DC, et al.
Investigational New Drugs, 34(1), 41-48 (2016)
Ezetimibe suppresses development of liver tumors by inhibiting angiogenesis in mice fed a high-fat diet
Miura K, et al.
Cancer Science, 110(2), 771-771 (2019)
Matthew R Sobansky et al.
Analytical and bioanalytical chemistry, 403(2), 563-571 (2012-02-23)
Columns containing immobilized low-density lipoprotein (LDL) were prepared for the analysis of drug interactions with this agent by high-performance affinity chromatography (HPAC). R/S-Propranolol was used as a model drug for this study. The LDL columns gave reproducible binding to propranolol

Articles

Lipoproteins package cholesterol for transport in plasma, essential for lipid transport and cellular function in the body.

Lipoproteins package cholesterol for transport in plasma, essential for lipid transport and cellular function in the body.

Lipoproteins package cholesterol for transport in plasma, essential for lipid transport and cellular function in the body.

Lipoproteins package cholesterol for transport in plasma, essential for lipid transport and cellular function in the body.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service